Beit Jala Pharmaceutical Company reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was JOD 2.65 million compared to JOD 2.41 million a year ago. Net income was JOD 0.379253 million compared to JOD 0.255073 million a year ago. Basic earnings per share from continuing operations was JOD 0.052 compared to JOD 0.036 a year ago.